29 abril 2015
Because depression in brain cancer patients is a common but often overlooked condition, oncologists should regularly screen tumor patients for depression, according to a new article. The authors also propose that more studies be completed to explore the efficacy of anti-depression treatments, as well as the value of depression biomarkers for future brain tumor research.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/lAgchMO3q2A/150429090112.htm
